PAR 0.00% 19.5¢ paradigm biopharmaceuticals limited..

Mesoblast

  1. 119 Posts.
    lightbulb Created with Sketch. 10
    Mesoblast announced the settlement of a consolidated shareholder class action two days ago. The suit alleged Mesoblast made materially misleading statements and omissions causing their share price to be artificially inflated and when the truth was revealed, the price declined. PR and DS were employed at Mesoblast during that time.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.